Urology Trade Association
Webinar panel discussion: What is the role of medical device regulation post-Brexit?
Thursday 22nd April, 10:00am – Zoom
The Whitehouse Consultancy, on behalf of the Urology Trade Association is hosting a webinar panel discussion on the role of medical device regulation post-Brexit.
Following the UK’s departure from the EU, the Medicines and Healthcare products Regulatory Agency (MHRA) is now the UK’s standalone medicines and medical devices regulator. This means, that the UK has control over how medical devices, including urology products, are placed on the market in the UK. The MHRA has the opportunity to make the UK a world-leading regulatory environment in harmony with its partner organisations such as NICE and NHS England.
Panellists will discuss how the UK can take advantage of opportunities for a regulatory leadership role following the UK’s exit from the European Union. Our panelists will focus on the barriers to access for medical devices, as well as the opportunities for a regulatory leadership role on the international stage.
The event will hear from:
- Graeme Tunbridge, Director of Devices at MHRA
- Anne Marie Morris, MP for Newton Abbot and Chair of the All-Party Parliamentary Group on Access to Medicines and Medical Devices
- Peter Bullen, CEO of Bullen Healthcare, and member of the UTA
Chris Whitehouse, chair of the UTA, will lead the discussion, and there will be an opportunity for you to raise your own questions in the Q&A session planned.
The Whitehouse Communications team are experts in providing public affairs, consultancy advice and political analysis to a wide range of clients engaging with health and social care providers and policy makers, not only in the United Kingdom, but also across the member states of the European Union and beyond. For more information, please contact our Chairman and Director of Health and Social Care Policy, Chris Whitehouse, at email@example.com.
More articles on health, social care and public service reform are here.